NCT04732988View on ClinicalTrials.gov

A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics, and Food Effect of HSG4112

PHASE1CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 23, 2018

Primary Completion Date

May 24, 2021

Study Completion Date

May 24, 2021

Conditions
Obesity
Interventions
DRUG

HSG4112

Once-daily oral administration

DRUG

Placebo

Once-daily oral administration

Trial Locations (2)

41944

Kyungpook National University Hospital, Daegu

03080

Seoul National University Hospital, Seoul

Sponsors

Lead Sponsor

Glaceum
All Listed Sponsors
collaborator

Seoul National University Hospital

OTHER

collaborator

Kyungpook National University Hospital

OTHER

lead

Glaceum

INDUSTRY

NCT04732988 - A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics, and Food Effect of HSG4112 | Biotech Hunter | Biotech Hunter